PRESS NOTE
GREAT RECOGNITION FROM THE INSURANCE SECTOR! ARGERON RANKED FIRST IN TÜRKİYE:
Argeron, which can detect acute kidney injury before clinical symptoms appear — while creatinine and proteinuria are still normal — offers life-saving early diagnosis as a cost-effective solution that can be integrated into insurance systems.
The competition was organized by the Health and Insurance Executives Association (SASDER), whose members include insurance managers, private hospital representatives, and health finance experts. Argeron’s first place was determined directly by the votes of these members. This success demonstrates not only the power of our deep technology but also how accurately we address the strategic priorities of the sector.
Heartfelt thanks to the Executive Board members who meticulously managed this process: Prof. Dr. Melih Bulut, Bülent Varak, Assoc. Prof. Dr. Rukiye Numanoğlu Tekin, Dr. Şevval Karadağ, MD, Buket Saribal, Zeynep Türkel, and Volkan Özgül.
As Argeron, we are committed to making early diagnosis in healthcare possible through the power of biotechnology; building a more sustainable future for patients, doctors, and insurance systems.

